These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 18679715)

  • 1. The role of VEGF-C staining in predicting regional metastasis in melanoma.
    Boone B; Blokx W; De Bacquer D; Lambert J; Ruiter D; Brochez L
    Virchows Arch; 2008 Sep; 453(3):257-65. PubMed ID: 18679715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal expression of vascular endothelial growth factor C is relevant to predict sentinel lymph node status in melanomas.
    Gallego E; Vicioso L; Alvarez M; Hierro I; Pérez-Villa L; Blanes A; Matilla A
    Virchows Arch; 2011 May; 458(5):621-30. PubMed ID: 21279519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour lymphangiogenesis is a possible predictor of sentinel lymph node status in cutaneous melanoma: a case-control study.
    Massi D; Puig S; Franchi A; Malvehy J; Vidal-Sicart S; González-Cao M; Baroni G; Ketabchi S; Palou J; Santucci M
    J Clin Pathol; 2006 Feb; 59(2):166-73. PubMed ID: 16443733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
    Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
    J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in the Progression of Cutaneous Melanoma.
    Špirić Z; Eri Ž; Erić M
    Int J Surg Pathol; 2015 Dec; 23(8):629-37. PubMed ID: 25911567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphatic vessel density and VEGF-C expression as independent predictors of melanoma metastases.
    Špirić Z; Eri Ž; Erić M
    J Plast Reconstr Aesthet Surg; 2017 Nov; 70(11):1653-1659. PubMed ID: 28756123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma.
    Wobser M; Siedel C; Schrama D; Bröcker EB; Becker JC; Vetter-Kauczok CS
    Arch Dermatol Res; 2006 Feb; 297(8):352-7. PubMed ID: 16395613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of vascular endothelial growth factor-C in primary cutaneous melanoma predicts sentinel lymph node positivity.
    Cianfarani F; Mastroeni S; Odorisio T; Passarelli F; Cattani C; Mannooranparampil TJ; Fortes C; Failla CM
    J Cutan Pathol; 2012 Sep; 39(9):826-34. PubMed ID: 22804631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of LYVE-1 antibody for detecting lymphatic involvement in patients with malignant melanoma of known sentinel node status.
    Sahni D; Robson A; Orchard G; Szydlo R; Evans AV; Russell-Jones R
    J Clin Pathol; 2005 Jul; 58(7):715-21. PubMed ID: 15976338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.
    Schietroma C; Cianfarani F; Lacal PM; Odorisio T; Orecchia A; Kanitakis J; D'Atri S; Failla CM; Zambruno G
    Cancer; 2003 Aug; 98(4):789-97. PubMed ID: 12910524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes.
    Dadras SS; Lange-Asschenfeldt B; Velasco P; Nguyen L; Vora A; Muzikansky A; Jahnke K; Hauschild A; Hirakawa S; Mihm MC; Detmar M
    Mod Pathol; 2005 Sep; 18(9):1232-42. PubMed ID: 15803182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breslow thickness, clark index and ulceration are associated with sentinel lymph node metastasis in melanoma patients: a cohort analysis of 612 patients.
    Munsch C; Lauwers-Cances V; Lamant L; Gentil C; Rochaix P; Garrido I; Lopez R; Chevreau C; Paul C; Meyer N
    Dermatology; 2014; 229(3):183-9. PubMed ID: 25171688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical markers and driving mechanisms in melanoma progression: VEGF-C, RhoC, c-Ski/SnoN and EGFR.
    Boone B; Brochez L
    Verh K Acad Geneeskd Belg; 2009; 71(5):251-94. PubMed ID: 20232784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
    Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
    Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma.
    Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y
    Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-1/PD-L1 and VEGF-A/VEGF-C expression in lymph node microenvironment and association with melanoma metastasis and survival.
    Alessi C; Scapulatempo Neto C; Viana CR; Vazquez VL
    Melanoma Res; 2017 Dec; 27(6):565-572. PubMed ID: 28984690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.
    Statius Muller MG; van Leeuwen PA; de Lange-De Klerk ES; van Diest PJ; Pijpers R; Ferwerda CC; Vuylsteke RJ; Meijer S
    Cancer; 2001 Jun; 91(12):2401-8. PubMed ID: 11413531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.